Martin Welschof of Opsona Therapeutics joined us for World Orphan Drug Congress USA 2015 to present about ‘ Sending the Right Signals to the Immune System’.
Download the presentation now to understand more about:
- The value of targeting TLRs
- Opsona’s lead compound OPN-305
- Efficacy: convincing data in pre-clinical studies
- OPN-305 Overall Clinical Development Strategy
…and much more!
Get your copy here!
To find out more about Opsona Therapeutics and OPN-305 , join us at World Orphan Drug Congress USA 2016 April 20-22 in Washington, DC.